Table 4 SIR and SMR for Rhodes study area compared with New South Wales and compared with Ryde and Concord SLAs for lung and bronchus carcinoma and haematopoietic cancers (based on 30 year counts)
From: Effect of a chemical manufacturing plant on community cancer rates
Cancer type | Number of cases/ number of deaths in Rhodes study area | Comparison Area | Case SIR (Indirectly Standardised) | 95% Confidence Interval | Death SMR (Indirectly Standardised) | 95% Confidence Interval |
|---|---|---|---|---|---|---|
Lung and Bronchus Carcinomas | 143/121 | NSW | 105.5 | 88.9–124.2 | 107.1 | 88.9–128.0 |
Haematopoietic neoplasms | 85/46 | NSW | 80.6# | 64.3–99.6 | 80.8 | 59.2–107.8 |
Lung and Bronchus Carcinomas | 143/121 | Concord & Ryde SLAs | 115.7 | 97.5–136.3 | 116.2 | 96.4–138.8 |
Haematopoietic neoplasms | 85/46 | Concord & Ryde SLAs | 75.0# | 59.9–92.7 | 78.3 | 57.3–104.4 |